NMR Structure and Dynamics of Membrane Binding Proteins
NMR Structure and Dynamics of Membrane Binding Proteins
批准号:
6603472
负责人:
DAVID NIGEL JONES
金额:
$32.02万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-06-30
关键词:
Parkinson's disease alpha synuclein binding proteins circular dichroism fluorescence spectrometry glycine receptors intermolecular interaction intracellular transport lysosomes membrane lipids micelles molecular dynamics nuclear magnetic resonance spectroscopy point mutation protein folding protein structure surface plasmon resonance ultracentrifugation
中文摘要
描述(申请人提供):本项目的总体目标是使用多维异核磁共振(核磁共振)波谱来
表征三维(3D)结构、膜结合
生物重要性的机制、多聚化界面和动力学
与人类疾病有关的蛋白质。每个域被预测为代表一个
新的结构折叠,并已被证明直接结合或折叠在上面
膜。我们研究的具体目标是:
α-突触核蛋白:α-突触核蛋白是一种动态的140个残基蛋白,在酸性膜上折叠成螺旋结构,然后寡聚为
贝塔薄片原纤维。蛋白质被突变驱动进入后一种状态
与帕金森氏症有关。胶束结合和胶束结合的溶液结构
我们将阐明和比较α-突触核蛋白的游离态。该结构
连接酸性磷脂和金属的口袋将被定义为
在这个过程中,那些被磷酸化、亚硝化或截断的位点
聚合的过程。构象和动力学的变化
发生齐聚并折叠到胶束表面将是
调查过了。
甘氨酸受体:甘氨酸受体是一个超家族的原型成员
由甘氨酸、GABA调节的离子通道。5-羟色胺和烟碱型乙酰胆碱
神经递质。我们已经确定了甘氨酸的胞外结构域
受体通过有限的蛋白降解,并证明了它们的功能
正直。近100个残基神经递质的三维结构
该受体的结合结构域将通过核磁共振进行表征。的结构
激动剂、士的宁、磷脂、锌和多肽的结合部位
将定义到离子通道的信号。
海滩域:Chediak-Higashi综合征是一种潜在的致命人类遗传病,由CHSi蛋白及其海滩域突变引起
扰乱溶酶体的贩运。我们已经确定了这部小说的界限
大约150个残基结构域,并已表明它与脂类相关。
在这里,我们阐明了它的低聚状态和存在下的三维结构
胶束揭示膜相互作用和蛋白质的结构基础
承认。
DIX结构域:DIX结构域是一个新的约85个残基的信号模块,在Wnt信号通路中发挥关键作用
胚胎发育和癌症进展。该问题的解结构
蓬乱的和Axin DIX结构域的同源二聚体和单体将被阐明。这个
这些结构域的磷脂和蛋白质结合特性将是
以圆二色谱和荧光光谱为特征。这个
调节异二聚化和膜缔合的界面将是
经核磁共振、沉淀平衡和诱变实验鉴定
以定义这两个域的独特信号角色。
英文摘要
DESCRIPTION (provided by applicant): The overall aim of this project is to use multidimensional heteronuclear magnetic resonance (NMR) spectroscopy to
characterize the three dimensional (3D) structures, membrane binding
mechanisms, multimerization interfaces, and dynamics of biologically important
proteins involved in human disease. Each domain is predicted to represent a
novel structural fold and has been shown to bind directly to or fold on
membranes. The specific targets of our study are:
alpha-Synuclein: The alpha-synuclein protein is a dynamic 140 residue protein that folds into a helical structure on acidic membranes and oligomerizes into
beta sheet fibrils. The protein is driven into the latter state by mutations
linked to Parkinson's disease. The solution structures of the micelle-bound and
free states of alpha-synuclein will be elucidated and compared. The structure
of the pockets that ligate acidic phospholipids and metals will be defined, as
will the sites that become phosphorylated, nitrosylated, or truncated during
the course of polymerization. The changes in conformation and dynamics that
occur upon oligomerization and folding onto micelle surfaces will be
investigated.
Glycine Receptor: The glycine receptor is a prototypic member of a superfamily
of ion channels gated by glycine, GABA. serotonin, and nicotinic acetylcholine
neurotransmitters. We have identified the extracellular domains of the glycine
receptor by limited proteolysis and have demonstrated their functional
integrity. The 3D structure of the approximately 100 residue neurotransmitter
binding domain of this receptor will be characterized by NMR. The structure of
the binding sites for agonists, strychnine, phospholipids, zinc, and peptides
that signal to the ion channel will be defined.
BEACH Domain: The Chediak-Higashi syndrome is a potentially fatal human genetic disorder caused by mutations in the CHSI protein and its BEACH domain that
disrupt lysosomal trafficking. We have defined the boundaries of this novel
approximately 150 residue domain and have shown that it associates with lipids.
Here we elucidate its oligomeric state and 3D structure in the presence of
micelles to reveal the structural basis of membrane interaction and protein
recognition.
DIX Domain: The DIX domain is a novel approximately 85 residue signaling module that plays a key role in the Wnt signaling pathway that contributes to
embryonic development and cancer progression. The solution structures of
Disheveled and Axin DIX domain homodimers and monomers will be elucidated. The
phospholipid and protein binding properties of these domains will be
characterized by circular dichroism and fluorescence spectroscopy. The
interfaces that mediate heterodimerization and membrane association will be
identified by NMR, sedimentation equilibrium, and mutagenesis experiments in
order to define the unique signaling roles of these two domains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting chemosensory signaling in Aedes aegypti mosquitoes
-
批准号:9176663
-
项目类别:
-
资助金额:$49.88万
-
财政年份:2016
-
负责人:DAVID NIGEL JONES
-
依托单位:
The Molecular Basis of Alcohol's Actions
-
批准号:7929877
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2009
-
负责人:DAVID NIGEL JONES
-
依托单位:
The Molecular Basis of Alcohol's Actions
-
批准号:7730113
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2009
-
负责人:DAVID NIGEL JONES
-
依托单位:
Molecular basis of olfactory perception.
-
批准号:7755031
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2007
-
负责人:DAVID NIGEL JONES
-
依托单位:
Molecular basis of olfactory perception.
-
批准号:7388921
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2007
-
负责人:DAVID NIGEL JONES
-
依托单位:
Molecular basis of olfactory perception.
-
批准号:7559595
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2007
-
负责人:DAVID NIGEL JONES
-
依托单位:
Molecular basis of olfactory perception.
-
批准号:7245643
-
项目类别:
-
资助金额:$29.29万
-
财政年份:2007
-
负责人:DAVID NIGEL JONES
-
依托单位:
Molecular basis of olfactory perception.
-
批准号:8012829
-
项目类别:
-
资助金额:$27.69万
-
财政年份:2007
-
负责人:DAVID NIGEL JONES
-
依托单位:
CRYOPROBE FOR NMR STRUCTURAL STUDIES: PARKINSON'S DISEASE
-
批准号:6973381
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2004
-
负责人:DAVID NIGEL JONES
-
依托单位:
Cryoprobe for NMR structural studies
-
批准号:6731432
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2004
-
负责人:DAVID NIGEL JONES
-
依托单位:
CRYOPROBE FOR NMR STRUCTURAL STUDIES: STRUCTURAL BIOLOGY
-
批准号:6973379
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2004
-
负责人:DAVID NIGEL JONES
-
依托单位:
CRYOPROBE FOR NMR STRUCTURAL STUDIES: LEUKEMIA, CANCER
-
批准号:6973380
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2004
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions
-
批准号:6579484
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions.
-
批准号:6901735
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions.
-
批准号:7009331
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions.
-
批准号:6848351
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions.
-
批准号:7173837
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
The molecular basis of alcohol's actions.
-
批准号:6700728
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2003
-
负责人:DAVID NIGEL JONES
-
依托单位:
CORE--NUCLEAR MAGNETIC RESONANCE
-
批准号:6664442
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:DAVID NIGEL JONES
-
依托单位:
CORE--NUCLEAR MAGNETIC RESONANCE
-
批准号:6589987
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:DAVID NIGEL JONES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
磷酸化等修饰对TDP-43和Alpha-synuclein等淀粉样蛋白结构及相变的调控机制研究
-
批准号:92053108
-
项目类别:重大研究计划
-
资助金额:70.0万元
-
批准年份:2020
-
负责人:李艳梅
-
依托单位:
Alpha-Synuclein介导线粒体与突触囊泡相互作用在脑缺血损伤中的作用及机制研究
-
批准号:81971131
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:吴小梅
-
依托单位:
组蛋白去乙酰化酶2(HDAC2)在alpha-synuclein致小胶质细胞炎性因子异常表达中的作用及机制研究
-
批准号:81971183
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:谭玉燕
-
依托单位:
帕金森病中CDK5磷酸化依赖的C9orf72泛素化降解介导alpha-synuclein清除障碍和神经元死亡的机制研究
-
批准号:81860246
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:闫建国
-
依托单位:
G蛋白偶联雌激素受体调控alpha-synuclein清除参与帕金森病的机制研究
-
批准号:81703485
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:张吉
-
依托单位:
基于小分子偶联多肽技术的新型抗alpha-synuclein毒性聚集缀合物研究
-
批准号:81603013
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:程彪
-
依托单位:
alpha-synuclein诱导线粒体稳态失衡在帕金森病分子病理机制中的作用研究
-
批准号:31370763
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:李文军
-
依托单位:
Alpha-synuclein与Rab3a蛋白的相互作用及其对锰干扰氨基酸类神经递质释放的影响
-
批准号:81372942
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:徐斌
-
依托单位:
Calcineurin/NFAT信号通路在alpha-synuclein所致多巴胺能神经元损伤中的作用及其相应的药物干预
-
批准号:81373389
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2013
-
负责人:骆静
-
依托单位:
alpha-synuclein 和tau 蛋白体内相互作用机制的研究
-
批准号:81171211
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:林贤
-
依托单位: